Real-time enrollment status for this multiple myeloma (mm) clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:34 PM UTC
| NCT Number | NCT07280013 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma (MM) |
| Phase | PHASE1 |
| Target Enrollment | 60 participants |
| Active Locations | 20 sites in the US |
| Sponsor | C4 Therapeutics, Inc. |
| Last Updated on CT.gov | August 12, 2026 (Aug 12, 2026) |
As of October 12, 2026: Clinical trial NCT07280013 is currently recruiting participants. This phase1 study for multiple myeloma (mm) is actively seeking new participants at 20 locations across the United States. The study is sponsored by C4 Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07280013 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07280013 was last updated Aug 12, 2026 (August 12, 2026). HelloStudys verifies this status automatically.